Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury [...]
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury [...]
The Audiogene trial is designed to evaluate the safety, tolerability [...]
This article gives an overview of the new clinical trial [...]
“Neuropathy is incredibly common among the aging population, regardless of [...]
Dr. Joel Braunstein, CEO of C2N Diagnostics, says, “This research [...]
Interactive Response Technology (IRT) helps clinical trial sites and sponsors [...]
The GAMEFILM Registry will enroll approximately 120 NFL alumni. The [...]
“We are delighted to have treated the first patients – [...]
The focal point of the study is the growing role [...]
“These outstanding results underscore the potential of the Histolog Scanner [...]